| Association between time of statin initiation after hospital discharge from acute myocardial infarction and risk of recurrence and mortality in patients > or =65 years of age. | |
| | |
MedLine Citation:
|
PMID: 16442354 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Clinical studies have shown the benefit of statin use after acute myocardial infarction (AMI). However, it is uncertain how this benefit relates to the timing of statin initiation after AMI. We created a retrospective cohort (from 1996 to 2001) using health care databases in Quebec, Canada, to study patients (> or =65 years of age) who had AMI and differed in time of statin initiation within the first 90 days after discharge. Rates of recurrent AMI and mortality were compared between patients who initiated statins at discharge (early group) and those who initiated statins 1 month later and up to 90 days after discharge (delayed group). A multivariate Cox's regression model was used in the comparison. We used prescription time distribution matching to control for survival difference between groups. The early and delayed groups consisted of 3,075 and 1,187 patients, respectively. During the 1-year follow-up, there was no evidence to suggest a difference in outcome between groups. Adjusted hazard ratios for early versus delayed initiation were 1.03 (95% confidence interval 0.56 to 1.87) at 3 months and 1.24 (95% confidence interval 0.96 to 1.62) at 1 year. Analyses that were restricted to first-time statin users or excluded patients who had severe co-morbidity or were > or =85 years old did not change the results. Our findings were not affected by changing the definition of delayed use within the 90-day period. In conclusion, delay of statin initiation up to 30 to 90 days after discharge after AMI does not appear to lead to a difference in the rates of recurrent AMI and mortality compared with statin initiation at discharge. |
| | |
Authors:
|
Zheng Zhou; Elham Rahme; Louise Pilote |
Related Documents
:
|
4416064 - Ten years clinical experience with partial ileal bypass in management of the hyperlipid... 8729154 - Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusio... 9399614 - Experience with crystalline niacin as the preferred drug for dyslipidemia in a specialt... 19010194 - The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transpla... 23003204 - Advances in catheter ablation: atrial fibrillation ablation in patients with mitral mec... 23131504 - Initial brazilian experience in the treatment of localized prostate cancer using a new ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2005-11-16 |
Journal Detail:
|
Title: The American journal of cardiology Volume: 97 ISSN: 0002-9149 ISO Abbreviation: Am. J. Cardiol. Publication Date: 2006 Jan |
Date Detail:
|
Created Date: 2006-01-30 Completed Date: 2006-03-03 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 155-9 Citation Subset: AIM; IM |
Affiliation:
|
Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use* Male Myocardial Infarction / drug therapy*, epidemiology*, mortality Quebec Recurrence / prevention & control Retrospective Studies Time Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Assay of ochratoxin A in grape by high-pressure liquid chromatography coupled on line with an ESI-ma...
Next Document: Comparison of usefulness of left ventricular diastolic versus systolic function as a predictor of ou...